Table 1 Clinical and demographic data of the patient cohorts profiled for expression of obesity-related genes
Demographic or clinical parameter | Mean ± SD, or % |
|---|---|
(N = 24) | |
BMI (*) | 47.96 ± 8.2 |
AST, (U/L) (*) | 24.92 ± 8.37 |
ALT, (U/L) (*) | 30.38 ± 12.88 |
Total cholesterol, mg/dL (*) | 205.08 ± 41.82 |
HDL, mg/dL (*) Females | 50.33 ± 11.85 |
HDL, mg/dL (*) Males | 39.66 ± 41.82 |
Triglyceride, mg/dL (*) | 197 ± 105.39 |
Age | 43.93 ± 10.2 |
Gender (Females) | 79% (N = 19) |
Race (caucasian) | 67% (N = 16) |
Advanced inflammation (score ≥ 3) | 54% (N = 13) |
NASH | 63% (N = 15) |
Advanced steatosis | 42% (N = 10) |
Fibrosis | 79% (N = 19) |
Steatosis with presence of hepatic inflammation | 96% (N = 23) |
NASH with presence of hepatic inflammation | 62.5% (N = 15) |